Hyperliquid Strategies (NASDAQ:PURR) Stock Price Up 16.4% – Should You Buy?

Hyperliquid Strategies Inc (NASDAQ:PURR)’s stock price traded up 16.4% during trading on Monday . The stock traded as high as $4.97 and last traded at $4.75. 2,292,344 shares were traded during trading, a decline of 22% from the average session volume of 2,935,492 shares. The stock had previously closed at $4.08.

Wall Street Analyst Weigh In

Several equities research analysts have recently weighed in on the company. Cantor Fitzgerald increased their price target on Hyperliquid Strategies from $5.00 to $6.00 and gave the stock an “overweight” rating in a report on Thursday, February 12th. Wall Street Zen upgraded shares of Hyperliquid Strategies to a “hold” rating in a report on Saturday, February 21st. Finally, Chardan Capital boosted their price objective on shares of Hyperliquid Strategies from $8.15 to $8.45 and gave the company a “buy” rating in a research report on Thursday, February 12th. Two analysts have rated the stock with a Buy rating, According to data from MarketBeat, Hyperliquid Strategies currently has a consensus rating of “Buy” and an average price target of $7.23.

Hyperliquid Strategies Stock Up 18.9%

The stock has a market cap of $601.25 million, a PE ratio of -0.52 and a beta of 1.58.

Hyperliquid Strategies (NASDAQ:PURR) last issued its quarterly earnings data on Wednesday, February 11th. The company reported ($7.43) earnings per share for the quarter. The company had revenue of $0.50 million during the quarter.

Hedge Funds Weigh In On Hyperliquid Strategies

Several institutional investors and hedge funds have recently bought and sold shares of the company. Boothbay Fund Management LLC acquired a new stake in shares of Hyperliquid Strategies in the 4th quarter worth $40,000. XTX Topco Ltd acquired a new position in shares of Hyperliquid Strategies during the fourth quarter valued at about $48,000. Squarepoint Ops LLC purchased a new position in shares of Hyperliquid Strategies in the 4th quarter valued at approximately $73,000. Millennium Management LLC purchased a new stake in Hyperliquid Strategies during the 4th quarter worth approximately $87,000. Finally, Ikarian Capital LLC acquired a new position in Hyperliquid Strategies during the 4th quarter valued at approximately $107,000. 9.45% of the stock is owned by hedge funds and other institutional investors.

Hyperliquid Strategies Company Profile

Hyperliquid Strategies Inc is a digital asset treasury company whose primary focus is to maximize shareholder value through accumulating HYPE, the native token of Hyperliquid, a high-performance blockchain custom-built to house all of finance. Hyperliquid Strategies Inc, formerly known as Sonnet BioTherapeutics Holdings Inc, is based in NEW YORK.